{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:07:45Z","timestamp":1788584865115,"version":"build-2803163510"},"reference-count":12,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T00:00:00Z","timestamp":1512950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["EU\u2010FP7\u2010REGPOT\u2010316088"],"award-info":[{"award-number":["EU\u2010FP7\u2010REGPOT\u2010316088"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Genetics"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>Glycogen storage disease (<jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content>) type I is inborn metabolic disease characterized by accumulation of glycogen in multiple organs. We analyzed 38 patients with clinical suspicion of <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> I using Sanger and next\u2010generation sequencing (<jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>). We identified 28 <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> Ib and 5 GSD Ia patients. In 5 patients, <jats:styled-content style=\"fixed-case\">GSD III<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">VI<\/jats:styled-content>, <jats:styled-content style=\"fixed-case\">IX<\/jats:styled-content>, cholesteryl\u2010ester storage disease and Shwachman\u2010Diamond syndrome diagnoses were set using <jats:styled-content style=\"fixed-case\">NGS<\/jats:styled-content>. Incidences for <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> Ia and <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> Ib were estimated at 1:172\u2009746 and 1:60\u2009461 live\u2010births, respectively. Two variants were identified in <jats:italic><jats:styled-content style=\"fixed-case\">G6PC<\/jats:styled-content><\/jats:italic> gene: c.<jats:styled-content style=\"fixed-case\">247C<\/jats:styled-content>&gt;T (p.<jats:styled-content style=\"fixed-case\">Arg83Cys<\/jats:styled-content>) and c.<jats:styled-content style=\"fixed-case\">518T<\/jats:styled-content>&gt;C (p.<jats:styled-content style=\"fixed-case\">Leu173Pro<\/jats:styled-content>). In <jats:italic><jats:styled-content style=\"fixed-case\">SLC37A4<\/jats:styled-content><\/jats:italic> gene, 6 variants were detected. Three previously reported variants c.<jats:styled-content style=\"fixed-case\">81T<\/jats:styled-content>&gt;A (p.<jats:styled-content style=\"fixed-case\">Asn27Lys<\/jats:styled-content>), c.<jats:styled-content style=\"fixed-case\">162C<\/jats:styled-content>&gt;A (p.<jats:styled-content style=\"fixed-case\">Ser54Arg<\/jats:styled-content>) and c.1042_1043delCT (p.<jats:styled-content style=\"fixed-case\">Leu348Valfs<\/jats:styled-content>*53) accounted for 87% of all analyzed alleles. Computational, transcription studies and\/or clinical presentation in patients confirmed pathogenic effect of 3 novel variants: c.<jats:styled-content style=\"fixed-case\">248G<\/jats:styled-content>&gt;A (p.<jats:styled-content style=\"fixed-case\">Gly83Glu<\/jats:styled-content>), c.<jats:styled-content style=\"fixed-case\">404G<\/jats:styled-content>&gt;A (p.<jats:styled-content style=\"fixed-case\">Gly135Asp<\/jats:styled-content>) and c.<jats:styled-content style=\"fixed-case\">785G<\/jats:styled-content>&gt;A (p.<jats:styled-content style=\"fixed-case\">Ser263Glyfs<\/jats:styled-content>*33 or p.<jats:styled-content style=\"fixed-case\">Gly262Asp<\/jats:styled-content>). In the cohort, hepatomegaly, hypoglycemia and failure to thrive were the most frequent presenting signs of <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> Ia, while hepatomegaly and recurrent bacterial infections were clinical hallmarks of <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> Ib. All <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> Ib patients developed neutropenia while 20.6% developed inflammatory bowel disease. Our study revealed the highest worldwide incidence of <jats:styled-content style=\"fixed-case\">GSD<\/jats:styled-content> Ib. Furthermore, description of 3 novel variants will facilitate medical genetic practice.<\/jats:p>","DOI":"10.1111\/cge.13093","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T13:15:12Z","timestamp":1499433312000},"page":"350-355","source":"Crossref","is-referenced-by-count":25,"title":["Genetic characterization of <scp>GSD<\/scp> I in Serbian population revealed unexpectedly high incidence of <scp>GSD<\/scp> Ib and 3 novel <i><scp>SLC37A4<\/scp><\/i> variants"],"prefix":"10.1111","volume":"93","author":[{"given":"A.","family":"Skakic","sequence":"first","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Djordjevic","sequence":"additional","affiliation":[{"name":"Metabolic Department Mother and Child Health Care Institute of Serbia \u201cDr Vukan Cupic\u201d  Belgrade Serbia"},{"name":"School of Medicine University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sarajlija","sequence":"additional","affiliation":[{"name":"Metabolic Department Mother and Child Health Care Institute of Serbia \u201cDr Vukan Cupic\u201d  Belgrade Serbia"},{"name":"School of Medicine University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Klaassen","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tosic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kecman","sequence":"additional","affiliation":[{"name":"Metabolic Department Mother and Child Health Care Institute of Serbia \u201cDr Vukan Cupic\u201d  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ugrin","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Spasovski","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pavlovic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0625-2009","authenticated-orcid":false,"given":"M.","family":"Stojiljkovic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering University of Belgrade  Belgrade Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,12,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.128"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.217"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i18.2541"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.65254"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12751"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005677912539"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1006\/mgme.2001.3179"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-005-1657-4"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.30232"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-6-27"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1004(200008)16:2<177::AID-HUMU13>3.0.CO;2-8"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800223-0.00010-4"}],"container-title":["Clinical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcge.13093","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cge.13093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:25:46Z","timestamp":1695885946000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cge.13093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,11]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/cge.13093"],"URL":"https:\/\/doi.org\/10.1111\/cge.13093","archive":["Portico"],"relation":{},"ISSN":["0009-9163","1399-0004"],"issn-type":[{"value":"0009-9163","type":"print"},{"value":"1399-0004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,11]]}}}